Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis

Journal of Clinical Gastroenterology

Volumn 47, Issue 3, 2013, Pages 246-251

  Husain, Nisreen ^a   Tokoro, Ken ^a   Popov, Joanna M ^a   Naides, Stanley J ^a   Kwasny, Mary J ^b   Buchman, Alan L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

biomarker; C reactive protein; Crohn's disease; erythrocyte sedimentation rate; lactoferrin; neopterin; ulcerative colitis

Indexed keywords

NEOPTERIN;

ADULT; AGED; ARTICLE; CAPETOWN INDEX; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ACTIVITY INDEX; DISEASE SEVERITY; ENDOSCOPY; FECES ANALYSIS; FEMALE; HARVEY BRADSHAW INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; REMISSION; SENSITIVITY AND SPECIFICITY; SIMPLE CLINICAL COLITIS ACTIVITY INDEX; ULCERATIVE COLITIS; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; ENDOSCOPY; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPTERIN; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84873998179     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182582cdb     Document Type: Article

References (27)

1. Jorgensen LG, Fredholm L, Hyloft Peterson P, et al. How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)? Clin Chem Lab Med. 2005;43:403-411.
2. Langhorst J, Elsenbrunch S, Koelzer S, et al. Noninvasive markers of assessment of intestinal inflammation in inflammatory bowel disease: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162-169.
3. Florin TH, Paterson EW, Fowler EV, et al. Clinically active Crohn's disease in the presence of a low C-reactive protein. Scan J Gastroenterol. 2006;41:306-311.
4. Denis MA, Reenaers C, Fontaine F, et al. Assessment of endoscopic activity index and biological inflammatory markers in clinically active Crohn's disease with normal C-reactive protein level. Inflamm Bowel Dis. 2007;13:1100-1105.
5. Desai D, Faubion WA, Sandborne WJ. Review article: biological activity markers in inflammatory bowel disease. Aliment Pharmacol Ther. 2007;25:247-255.
6. Sutherland AD, Gearry RB, Frizelle FA. Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum. 2008;51:1283-1291.
7. Moscandrew ME, Loftus EV Jr. Diagnostic advances in inflammatory bowel disease (imaging and laboratory). Curr Gastroenterol Rep. 2009;11:488-495.
8. Beniwal P, Harrell L. The status of diagnostic markers for inflammatory bowel disease. Curr Gastroenterol Rep. 2010;12: 479-484.
9. Jones J, Loftus EV, Panaccione R, et al. Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol. 2008;6: 1218-1224.
10. Judmaier G, Meyersbach P,Weiss G, et al. The role of neopterin in assessing disease activity in Crohn's disease: classification and regression trees. Am J Gastroenterol. 1993;88:706-711.
11. Andert SE, Muller MM. Neopterin: biochemistry and clinical usefulness. J Int Fed Clin Chem. 1995;7:70-76.
12. Seki T, Sugie N, Joh K, et al. The regulation of neopterin production by cytokines. Pteridines. 1996;7:5-9.
13. Huber C, Batchelor JR, Fuchs D, et al. Immune response associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med. 1983;160:310-316.
14. Huber C, Fuchs D, Hausen A, et al. Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatability complex (MHC) determinants. J Immunol. 1983;130:1047-1050.
15. Schroecksnadel K, Frick B, Wirleitner B, et al. Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells. Clin Exp Immunol. 2003;134:53-56.
16. Prior CH, Bollbach R, Fuchs D, et al. Urinary neopterin, a marker of clinical activity in patients with Crohn's disease. Clin Chim Acta. 1986;155:11-22.
17. Konecny M, Ehrmann J, Bartek J, et al. The level of neopterin in blood serum as one of the possible prognostic markers of Crohn's disease activity. Acta Univ Palacki Olomuc Fac Med. 1996;140:47-48.
18. Nancey S, Perret-Liaudet A, Moussata D, et al. Urinary neopterin is a valuable tool in monitoring Crohn's disease activity. Inflamm Bowel Dis. 2008;14:1548-1554.
19. Reimund JM, Arondel Y, Escalin G, et al. Immune activation and nutritional status in adult Crohn's disease patients. Digestive Liver Dis. 2005;37:424-431.
20. Niederwieser D, Fuchs D, Hausen A, et al. Neopterin as a new biochemical marker in the clinical assessment of ulcerative colitis. Immunobiol. 1985;170:320-326.
21. Campbell DI, McPhail G, Lunn PG, et al. Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: association with growth failure, Giardia lamblia, and intestinal permeability. J Pediatr Gastroenterol Nutr. 2004;39:153-157.
22. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet. 1980;1:514.
23. Walmsley RS, Ayres RCS, et al. A simple clinical colitis activity index. Gut. 1988;43:29-32.
24. Wright JP, Marks IN, Parfitt A. A simple index of Crohn's disease activity. The Cape Town index. South African Med J. 1985;68:502-503.
25. Sutherland LR, Martin F, Greer S, et al. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, protosigmoiditis, and proctitis. Gastroenterology. 1987;92:1894-1898.
26. Duclos B, Reimund JM, Lang JM, et al. Activation of mononuclear cells in Crohn's disease. Gastroenterol Clin Biol. 1990;14:22-27.
27. Gisbert JP, McNicholl AG, Gomollon F. Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflamm Bowel Dis. 2009;15: 1746-1754.